U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684911) titled 'Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers' on June 23.
Brief Summary: Despite advances in the effective treatment of major depressive disorder using repetitive transcranial magnetic stimulation (rTMS), the processes that determine a patient's response trajectory remain poorly understood.
Currently, there are no validated clinical or neurophysiological markers that can identify factors predicting the durability of the response to rTMS at the individual level. This constitutes a major limitation for planning individualised treatments and highlights the need for precision medic...